Planning Alternatives’s DexCom DXCM Stock Holding History

Planning Alternatives’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,669	Closed	-$303K	–	60
2024 Q2	$303K	Buy	+2,669	New	+$337K	0.05%	47

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Planning Alternatives's DXCM Position: Q3 2024 in Review

Planning Alternatives sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,669 shares — an estimated $303K sold.

Planning Alternatives first reported a position in DXCM in Q2 2024 and held it in 1 quarter. The position peaked at $303K in Q2 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Planning Alternatives reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Planning Alternatives sold 2,669 DexCom shares in Q3 2024, an estimated $303K.
Planning Alternatives first reported a position in DexCom in Q2 2024 and held it in 1 quarter.
Planning Alternatives's DexCom position peaked at $303K in Q2 2024.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Planning Alternatives's 13F filing for Q3 2024, filed 12 Nov 2024.